Investing
Investment Proceeds
Bristol-Myers Squibb Investment Proceeds increased by 58.2% to $829.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 248.3%, from $238.00M to $829.00M. Over 3 years (FY 2021 to FY 2024), Investment Proceeds shows a downward trend with a -35.6% CAGR.
Analysis
StatementCash Flow Statement
SectionInvesting
CategoryLiquidity
SignalContext dependent
VolatilityVolatile
First reportedQ4 2013
Last reportedQ4 2025
How to read this metric
Higher inflows signal a conversion of financial assets back into cash, often used to fund dividends, buybacks, or capital projects.
Detailed definition
The total cash inflow generated from the sale or maturity of marketable securities and other investment instruments. Thi...
Peer comparison
Peer companies with significant 'cash piles' frequently rotate these assets, resulting in large offsetting inflows and outflows.
Metric ID:
cf_proceeds_from_investmentsHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.19B | $984.00M | $1.24B | $2.10B | $1.69B | $1.42B | $1.21B | $57.00M | $270.00M | $365.00M | $41.00M | $747.00M | $75.00M | $238.00M | $62.00M | $220.00M | $524.00M | $829.00M |
| QoQ Change | — | -17.0% | +26.4% | +68.8% | -19.6% | -16.1% | -14.9% | -95.3% | +373.7% | +35.2% | -88.8% | >999% | -90.0% | +217.3% | -73.9% | +254.8% | +138.2% | +58.2% |
| YoY Change | — | — | — | — | +42.3% | +44.0% | -3.1% | -97.3% | -84.0% | -74.2% | -96.6% | >999% | -72.2% | -34.8% | +51.2% | -70.5% | +598.7% | +248.3% |
Range$41.00M – $2.10B
CAGR-8.1%
Avg YoY Growth+118.7%
Median YoY Growth-18.9%
Current Streak3 quarters growth
Investment Proceeds at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's investment proceeds?
- Bristol-Myers Squibb (BMY) reported investment proceeds of $829.00M in Q3 2025.
- How has Bristol-Myers Squibb's investment proceeds changed year-over-year?
- Bristol-Myers Squibb's investment proceeds increased by 248.3% year-over-year, from $238.00M to $829.00M.
- What is the long-term trend for Bristol-Myers Squibb's investment proceeds?
- Over 3 years (2021 to 2024), Bristol-Myers Squibb's investment proceeds has grown at a -35.6% compound annual growth rate (CAGR), from $4.20B to $1.12B.
- What does investment proceeds mean?
- The cash received when a company sells its investments or when those investments reach their end date.